Ledger.Open graph →
SEC Form D · filed December 9, 2014

Ascendis Pharma A/S

Offering
$60.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HELLERUP, Netherlands
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Jan M. Mikkelsen · Hellerup, NetherlandsExec · DirectorMartin W. Auster · Hellerup, NetherlandsExecJames W. Healy · Hellerup, NetherlandsDirectorGrethe W. Rasmussen · Hellerup, NetherlandsExecHarald W. Rau · Hellerup, NetherlandsExecRafa?Le W. Tordjman · Hellerup, NetherlandsDirectorMartin W. Olin · Hellerup, NetherlandsDirectorLotte W. S?Nderbjerg · Hellerup, NetherlandsExecJonathan W. Silverstein · Hellerup, NetherlandsDirectorMichael W. Jensen · Hellerup, NetherlandsExec · DirectorMichael W. Mayer · Hellerup, NetherlandsDirectorEdwin W. De Graaf · Hellerup, NetherlandsDirectorThomas W. Soloway · Hellerup, NetherlandsExecAlbert W. Cha · Hellerup, NetherlandsDirectorJames W. Healy · Hellerup, NetherlandsDirectorGrethe W. Rasmussen · Hellerup, NetherlandsExecHarald W. Rau · Hellerup, NetherlandsExecRafa?Le W. Tordjman · Hellerup, NetherlandsDirectorMartin W. Olin · Hellerup, NetherlandsDirectorJan M. Mikkelsen · Hellerup, NetherlandsExec · DirectorLotte W. S?Nderbjerg · Hellerup, NetherlandsExecMartin W. Auster · Hellerup, NetherlandsExecJonathan W. Silverstein · Hellerup, NetherlandsDirectorMichael W. Jensen · Hellerup, NetherlandsExec · DirectorMichael W. Mayer · Hellerup, NetherlandsDirectorEdwin W. De Graaf · Hellerup, NetherlandsDirectorThomas W. Soloway · Hellerup, NetherlandsExecAlbert W. Cha · Hellerup, NetherlandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗